{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:15:28Z","timestamp":1706228128542},"reference-count":81,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205484","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:45:50Z","timestamp":1706201150000},"source":"Crossref","is-referenced-by-count":0,"title":["5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia"],"prefix":"10.18632","author":[{"given":"Yuhong","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Nantong University, Jiangsu 226000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhilesh K.","family":"Bajpai","sequence":"additional","affiliation":[{"name":"Department of Genetics, Genomics and Informatics University of Tennessee Health Science Cente, Memphis, TN 38163, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxia","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Nantong University, Jiangsu 226000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, The Branch Affiliated Hospital of Nantong University, Jiangsu 226000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Nantong University, Jiangsu 226000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Nantong University, Jiangsu 226000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Nantong University, Jiangsu 226000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Nantong University, Jiangsu 226000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Genetics, Genomics and Informatics University of Tennessee Health Science Cente, Memphis, TN 38163, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Nantong University, Jiangsu 226000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","article-title":"Advances in acute myeloid leukemia.","volume":"37","author":"Cook","year":"2021","journal-title":"BMJ"},{"key":"2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions.","volume":"1","author":"Ravandi","year":"2021","journal-title":"Blood Cancer J"},{"key":"3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.","volume":"3","author":"Zeidan","year":"2019","journal-title":"Blood Rev"},{"key":"4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1289\/ehp.98106s4937","article-title":"Biomarkers of leukemia risk: benzene as a model.","volume":"10","author":"Zhang","year":"1998","journal-title":"Environ Health Perspect"},{"key":"5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.","volume":"38","author":"Leber","year":"2020","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1056\/NEJMoa2004444","article-title":"Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.","volume":"38","author":"Turgut","year":"2020","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","article-title":"Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.","volume":"38","author":"Di Stasi","year":"2019","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41375-018-0312-9","article-title":"Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.","volume":"3","author":"Laird","year":"2019","journal-title":"Leukemia"},{"key":"9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/gm551","article-title":"Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia.","volume":"6","author":"Kim-Wanner","year":"2014","journal-title":"Genome Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40364-021-00293-w","article-title":"Functions of RNA N-methyladenosine modification in acute myeloid leukemia.","volume":"9","author":"Gong","year":"2021","journal-title":"Biomark Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1182\/blood.2021011707","article-title":"A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication.","volume":"13","author":"Huang","year":"2021","journal-title":"Blood"},{"key":"12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.","volume":"3","author":"Lian","year":"2019","journal-title":"Cancer Cell"},{"key":"13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood.2020005693","article-title":"Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia.","volume":"13","author":"Zhang","year":"2022","journal-title":"Blood"},{"key":"14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications.","volume":"1","author":"He","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","article-title":"The epitranscriptome beyond mA.","volume":"2","author":"Schwartz","year":"2021","journal-title":"Nat Rev Genet"},{"key":"16","doi-asserted-by":"publisher","first-page":"e1639","DOI":"10.1002\/wrna.1639","article-title":"Dynamic transcriptomic mC and its regulatory role in RNA processing.","volume":"1","author":"Yang","year":"2021","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"17","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.7150\/ijbs.61439","article-title":"The role of RNA mC modification in cancer metastasis.","volume":"1","author":"Zhang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/gb4143","article-title":"Characterizing 5-methylcytosine in the mammalian epitranscriptome.","volume":"1","author":"Frye","year":"2013","journal-title":"Genome Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","article-title":"The role of mA, mC and \u03a8 RNA modifications in cancer: Novel therapeutic opportunities.","volume":"2","author":"Blanco","year":"2021","journal-title":"Mol Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-022-00362-8","article-title":"Biological roles of RNA mC modification and its implications in Cancer immunotherapy.","volume":"1","author":"Ma","year":"2022","journal-title":"Biomark Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","article-title":"RNA modifications: importance in immune cell biology and related diseases.","volume":"7","author":"Shi","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.semcancer.2020.11.007","article-title":"RNA methylations in human cancers.","volume":"7","author":"Yang","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.omtn.2021.08.020","article-title":"Advances in mRNA 5-methylcytosine modifications: Detection, effectors, biological functions, and clinical relevance.","volume":"2","author":"Zhang","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"24","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels.","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia.","volume":"56","author":"Borate","year":"2018","journal-title":"Nature"},{"key":"26","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.","volume":"36","author":"Heath","year":"2013","journal-title":"N Engl J Med"},{"key":"27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","article-title":"The diverse roles of DNA methylation in mammalian development and disease.","volume":"2","author":"Bourc'his","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer.","volume":"3","author":"Nakanishi","year":"2021","journal-title":"Trends Genet"},{"key":"29","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1182\/blood-2008-02-134411","article-title":"An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.","volume":"11","author":"Larson","year":"2008","journal-title":"Blood"},{"key":"30","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3324\/haematol.2017.178442","article-title":"A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia.","volume":"10","author":"Schneider","year":"2018","journal-title":"Haematologica"},{"key":"31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.","volume":"17","author":"Galinsky","year":"2019","journal-title":"Cell"},{"key":"32","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201912-2445OC","article-title":"Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell.","volume":"20","author":"Sherman","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41591-020-0910-8","article-title":"Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents.","volume":"2","author":"Moshir","year":"2020","journal-title":"Nat Med"},{"key":"34","doi-asserted-by":"publisher","first-page":"140179","DOI":"10.1172\/jci.insight.140179","article-title":"Risk-associated alterations in marrow T cells in pediatric leukemia.","volume":"5","author":"Qiu","year":"2020","journal-title":"JCI Insight"},{"key":"35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer.","volume":"2","author":"Kouzarides","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer.","volume":"1","author":"Yin","year":"2019","journal-title":"Mol Cancer"},{"key":"37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","article-title":"Insights into N6-methyladenosine and programmed cell death in cancer.","volume":"2","author":"Zhang","year":"2022","journal-title":"Mol Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in Cancer progression.","volume":"1","author":"Ju","year":"2020","journal-title":"Mol Cancer"},{"key":"39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","article-title":"The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.","volume":"5","author":"Deng","year":"2022","journal-title":"Exp Mol Med"},{"key":"40","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.","volume":"59","author":"Fosbeary","year":"2021","journal-title":"Nature"},{"key":"41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41467-018-03513-4","article-title":"RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.","volume":"9","author":"Vardiman","year":"2018","journal-title":"Nat Commun"},{"key":"42","doi-asserted-by":"publisher","first-page":"9858","DOI":"10.18632\/aging.205059","article-title":"m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia.","volume":"1","author":"Li","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"43","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia.","volume":"36","author":"Townsend","year":"2010","journal-title":"N Engl J Med"},{"key":"44","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/nchem.2064","article-title":"5-Hydroxymethylcytosine is a predominantly stable DNA modification.","volume":"6","author":"Balasubramanian","year":"2014","journal-title":"Nat Chem"},{"key":"45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40246-020-00265-5","article-title":"Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment?","volume":"1","author":"Gao","year":"2020","journal-title":"Hum Genomics"},{"key":"46","doi-asserted-by":"publisher","first-page":"11994","DOI":"10.1073\/pnas.1310656110","article-title":"TET1 plays an essential oncogenic role in MLL-rearranged leukemia.","volume":"11","author":"Arnovitz","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"47","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2217\/epi-2016-0008","article-title":"Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulation.","volume":"8","author":"Melnick","year":"2016","journal-title":"Epigenomics"},{"key":"48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.","volume":"1","author":"Wolniak","year":"2010","journal-title":"Cancer Cell"},{"key":"49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41540-019-0116-1","article-title":"An omnidirectional visualization model of personalized gene regulatory networks.","volume":"5","author":"Wu","year":"2019","journal-title":"NPJ Syst Biol Appl"},{"key":"50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.physrep.2021.01.003","article-title":"Recovering dynamic networks in big static datasets.","volume":"91","author":"Jiang","year":"2021","journal-title":"Phys Rep"},{"key":"51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12920-017-0253-6","article-title":"Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications.","volume":"1","author":"Zare","year":"2017","journal-title":"BMC Med Genomics"},{"key":"52","doi-asserted-by":"publisher","first-page":"5423694","DOI":"10.1155\/2022\/5423694","article-title":"Identification of Survival-Related Genes in Acute Myeloid Leukemia (AML) Based on Cytogenetically Normal AML Samples Using Weighted Gene Coexpression Network Analysis.","volume":"202","author":"Zhou","year":"2022","journal-title":"Dis Markers"},{"key":"53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","article-title":"Subtype-specific regulatory network rewiring in acute myeloid leukemia.","volume":"5","author":"Beggs","year":"2019","journal-title":"Nat Genet"},{"key":"54","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/cancers12082086","article-title":"Computational Identification of Gene Networks as a Biomarker of Neuroblastoma Risk.","volume":"1","author":"Wu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.64.12.25","article-title":"Exploring Early-Stage Retinal Neurodegeneration in Murine Pigmentary Glaucoma: Insights From Gene Networks and miRNA Regulation Analyses.","volume":"6","author":"Lu","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"56","doi-asserted-by":"publisher","first-page":"1009462","DOI":"10.3389\/fgene.2023.1009462","article-title":"Weighted gene co-expression network analysis identifies key hub genes and pathways in acute myeloid leukemia.","volume":"1","author":"Lu","year":"2023","journal-title":"Front Genet"},{"key":"57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccell.2022.02.006","article-title":"The proteogenomic subtypes of acute myeloid leukemia.","volume":"4","author":"Wilke","year":"2022","journal-title":"Cancer Cell"},{"key":"58","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ajh.26141","article-title":"The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia.","volume":"9","author":"Seashore-Ludlow","year":"2021","journal-title":"Am J Hematol"},{"key":"59","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41467-021-21233-0","article-title":"Biological and therapeutic implications of a unique subtype of NPM1 mutated AML.","volume":"1","author":"Rantalainen","year":"2021","journal-title":"Nat Commun"},{"key":"60","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/2159-8290.CD-18-0774","article-title":"Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed\/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.","volume":"9","author":"Pemmaraju","year":"2019","journal-title":"Cancer Discov"},{"key":"61","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3324\/haematol.2017.187385","article-title":"CD16NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice.","volume":"10","author":"Keating","year":"2018","journal-title":"Haematologica"},{"key":"62","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12185-015-1865-2","article-title":"Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia.","volume":"10","author":"Liu","year":"2015","journal-title":"Int J Hematol"},{"key":"63","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1158\/1078-0432.CCR-11-2939","article-title":"Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment.","volume":"1","author":"Gabrilovich","year":"2012","journal-title":"Clin Cancer Res"},{"key":"64","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1182\/blood-2016-07-730614","article-title":"MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.","volume":"12","author":"Nahas","year":"2017","journal-title":"Blood"},{"key":"65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2165\/00003495-200868040-00004","article-title":"Nelarabine.","volume":"6","author":"Lyseng-Williamson","year":"2008","journal-title":"Drugs"},{"key":"66","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2165\/00003495-199244040-00009","article-title":"Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).","volume":"4","author":"Brogden","year":"1992","journal-title":"Drugs"},{"key":"67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12879-021-06045-3","article-title":"Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial.","volume":"2","author":"Gholampoor Saadi","year":"2021","journal-title":"BMC Infect Dis"},{"key":"68","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2165\/11204810-000000000-00000","article-title":"Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women.","volume":"7","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11864-014-0285-5","article-title":"Update on the biology and treatment options for hairy cell leukemia.","volume":"1","author":"Ravandi","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/WNF.0b013e318204cd90","article-title":"Cladribine: mode of action and implications for treatment of multiple sclerosis.","volume":"3","author":"Weissert","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"71","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1128\/AAC.48.6.2116-2123.2004","article-title":"Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum.","volume":"4","author":"Cheng","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"72","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.drudis.2022.02.001","article-title":"A graph model of combination therapies.","volume":"2","author":"Wu","year":"2022","journal-title":"Drug Discov Today"},{"key":"73","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/1471-2105-13-335","article-title":"Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R\/Bioconductor packages.","volume":"1","author":"Now\u00e9","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"74","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods.","volume":"8","author":"Rabinovic","year":"2007","journal-title":"Biostatistics"},{"key":"75","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer.","volume":"2","author":"Koeffler","year":"2018","journal-title":"Genome Res"},{"key":"76","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.","volume":"2","author":"Hayes","year":"2010","journal-title":"Bioinformatics"},{"key":"77","first-page":"1","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent.","volume":"3","author":"Tibshirani","year":"2010","journal-title":"J Stat Softw"},{"key":"78","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1198\/tech.2002.s656","article-title":"Modeling survival data: extending the Cox model.","volume":"4","author":"Zelterman","year":"2002","journal-title":"Technometrics"},{"key":"79","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.","volume":"6","author":"Gfeller","year":"2017","journal-title":"Elife"},{"key":"80","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.","volume":"4","author":"Yang","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:45:57Z","timestamp":1706201157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":81,"alternative-id":["205484"],"URL":"https:\/\/doi.org\/10.18632\/aging.205484","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]}}}